Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Gel in Stage II/III Periodontitis
NCT07892261Completed
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Randomised trial of levofloxacin in periodontitis (2 arms). Primary endpoints: Probing depth at 6 months, Clinical Attachment Loss at 6 months and 3 more. Started Aug 2024; status: completed.
02
Drugs
levofloxacin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07892261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07892261.